Skip to main content
. 2017;18(1):189–194. doi: 10.22034/APJCP.2017.18.1.189

Table 4.

Overall Survival (OS) and Recurrence Free Survival (RFS) of Studied Patients

Total patients TACE+RFA TACE+Microwave P value
Overall survival 0.08
 (27 months)
 1 year 80.10% 73.10% 83.30%
 2 years 55% 40.60% 64.70%
 3 years 36.30% 16.20% 64.70%
Overall survival in relation to tumor size 0.3
 focal lesion ≤ 3cm 27 months 50 months
 focal lesion > 3cm 21 months 22 months
Recurrence Free Survival 0.1
 1 year 70% 81.20%
 2 years 42% 65.10%
 3 years 14% 65.10%